Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer

  1. Palomeras, S.
  2. Diaz-Lagares, Á.
  3. Viñas, G.
  4. Setien, F.
  5. Ferreira, H.J.
  6. Oliveras, G.
  7. Crujeiras, A.B.
  8. Hernández, A.
  9. Lum, D.H.
  10. Welm, A.L.
  11. Esteller, M.
  12. Puig, T.
Journal:
Breast Cancer Research

ISSN: 1465-542X,  1465-5411

Year of publication: 2019

Volume: 21

Issue: 1

Type: Article

DOI: 10.1186/S13058-019-1160-X GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus